Sociedad Internacional de Rejuvenecimiento Facial no Quirúrgico (SIRF), Barranquilla, Colombia.
Sociedad Argentina de Dermatología, Buenos Aires, Argentina.
J Cosmet Dermatol. 2024 Jun;23(6):2001-2006. doi: 10.1111/jocd.16264. Epub 2024 Mar 21.
Eyelid ptosis is characterized by an inferior displacement of the upper eyelid when the eye assumes its primary position. Besides its aesthetic implications, ptosis can also adversely affect visual acuity.
This study aimed to evaluate the simultaneous administration of IncobotulinumtoxinA (IncoBonTA) and hyaluronic acid effect in eyelid ptosis and ocular rejuvenation.
A novel, non-surgical technique for eyelid ptosis management involving IncoBonTA and hyaluronic acid the co-administration within a single syringe, and applied using a cannula.
The dual action of IncoBonTA and hyaluronic acid in conjunction with the exact injection sites approaches improves overall aesthetic outcomes but also optimizes the restoration of eyelid functionality in palpebral ptosis.
The functional balance achieved among the contributory muscles-primarily the orbicularis oculi (OO) and its antagonists, the frontal muscle and levator palpebrae superioris (LPS), yields to both, cosmetic and functional.
眼睑下垂是指眼睛处于正视位时，上眼睑的向下移位。除了影响美观外，下垂还会对视力产生不利影响。
本研究旨在评估保妥适（IncobotulinumtoxinA，IncoBonTA）和透明质酸同时给药对眼睑下垂和眼部年轻化的效果。
一种新的非手术眼睑下垂治疗方法，涉及在同一个注射器中同时给予 IncoBonTA 和透明质酸，并使用套管进行注射。
IncoBonTA 和透明质酸的双重作用，结合精确的注射部位，不仅提高了整体美学效果，而且优化了眼睑下垂的眼睑功能恢复。
在眼轮匝肌（orbicularis oculi，OO）及其拮抗肌——额肌和上睑提肌（levator palpebrae superioris，LPS）之间实现的功能平衡，既可以达到美容效果，也可以达到功能效果。
